Private Credit Infrastructure Goes Fully On-Chain with Automated Compliance
Private Credit Infrastructure Goes Fully On-Chain with Automated Compliance
馃彟 Private credit goes programmable
Private credit operations are now fully executable on-chain. Credilabs and Turtle have launched infrastructure built on Enzyme Protocol that handles loan mechanics, collateral management, and settlement flows entirely on-chain with integrated compliance controls.
Key innovation: Direct settlement architecture
- Payment proceeds route directly from merchant acquirers to tokenized credit funds
- Borrowers are removed from the payment loop entirely
- Automates short-duration receivables flow
- Secures investor returns through programmatic enforcement
This represents a shift from traditional private credit operations to blockchain-native infrastructure where loan terms, collateral requirements, and payment flows are enforced by smart contracts rather than manual processes.
The infrastructure is now live and available for other asset managers looking to bring real-world yield strategies on-chain through Enzyme's Onyx product.
Direct settlement is the new standard for private credit. By routing proceeds from the Merchant Acquirer straight to the聽private credit tokenized fund, @credilabs removes the borrower from the payment loop entirely. Built on Enzyme via @turtledotxyz, this structure automates the
Private credit is moving on-chain. Loan mechanics, collateral management, settlement flows... all enforced on-chain with full compliance controls. @credilabs and @turtledotxyz launched exactly that, built on Enzyme. 馃憞
Direct settlement is the new standard for private credit. By routing proceeds from the Merchant Acquirer straight to the聽private credit tokenized fund, @credilabs removes the borrower from the payment loop entirely. Built on Enzyme via @turtledotxyz, this structure automates the
Enzyme Partners with Rayls Labs for Institutional Tokenized Funds
Enzyme Protocol is partnering with Rayls Labs as a launch partner, bringing institutional-grade tokenized fund infrastructure to the platform from day one. **Key Details:** - Enzyme's Onyx and Myso products will be available on Rayls at launch - The partnership provides institutional-grade infrastructure for tokenized funds - Onyx enables fund managers to access lending markets like Morpho and Fluid directly within tokenized fund structures This collaboration aims to reduce infrastructure constraints for early-stage investment opportunities while maintaining institutional standards. Read the full announcement: [Enzyme arrives on Rayls](https://enzyme.finance/blog-posts/enzyme-arrives-on-rayls)
馃敡 Onyx Timing Strategy
**Enzyme Onyx** addresses different protocol needs across three key stages: - **Pre-TGE**: Early participation incentives to build community - **Post-TGE**: Strengthen Total Value Locked (TVL) after token launch - **Mature stage**: Manage liquidity across multiple assets including stablecoins and liquid staking tokens The platform provides structured, on-chain strategies that protocols can adopt when timing is right for their development phase. Each stage requires different tooling approaches, but most protocols eventually need comprehensive on-chain financial infrastructure. [Explore Onyx](https://enzyme.finance/products/onyx?utm_source=x&utm_medium=organic&utm_content=post)
Chainlink CRE Automates Multi-Chain Asset Reporting for Fund Managers
**Multi-chain complexity solved**: As investment products expand across different blockchains, reporting becomes increasingly complex for asset managers. **Automated data sourcing**: Chainlink's CRE (Crypto Reporting Engine) automatically pulls and verifies NAV and performance data from: - On-chain sources - Centralized finance platforms - Traditional financial systems **Pain point addressed**: The solution eliminates manual reporting work that previously required tracking assets across multiple chains and platforms. **Verification built-in**: All data is automatically verified, reducing errors and ensuring accuracy for compliance and investor reporting.
Enzyme.Myso Introduces Institutional-Grade Options for On-Chain Yield Generation
Enzyme.Myso is advancing DeFi with institutional-grade on-chain options trading. The platform offers: - Native on-chain options strategies - Fully auditable transaction flows - Infrastructure designed for DAOs and institutions **Real-world implementation**: Compound DAO recently integrated covered calls into their treasury strategy using Enzyme.Myso, targeting approximately 15% APY while maintaining controlled risk exposure. This development signals a shift in how DAOs can optimize idle capital through sophisticated options strategies. *Learn more at* [Enzyme Finance](http://enzyme.finance/products/myso)
Tokenized Securities Market Projected to Reach $45T by 2030
Major financial institutions are forecasting significant growth in tokenized assets: - Citi projects tokenized securities market could reach $45T by 2030 - WEF estimates 10% of global GDP could be blockchain-tokenized by 2027 - McKinsey reports shift from pilot to at-scale deployment Key trends expected in next cycle: - Shift to natively tokenized funds - Increased institutional adoption - Integration with DeFi infrastructure - Clearer regulatory framework Traditional finance faces challenges from outdated systems, while tokenized vehicles offer programmability and global accessibility. Enzyme Protocol is positioning to support this transition with native tokenization capabilities. [Learn more about tokenized funds](http://enzyme.finance/use-cases/tokenized-funds)